Retour sur lavenir.net
   UCB 235.900 € (-0,76 %)     MELEXIS 68.550 € (-3,99 %)     KINEPOLIS GROUP 37.900 € (-0,79 %)     NYRSTAR 0.060 € (0,00 %)     ONTEX GROUP 2.320 € (-0,85 %)     SYENSQO 68.150 € (-0,44 %)     KBC 120.350 € (-1,35 %)     ARGENX SE 743.200 € (-0,93 %)     BARCO 7.805 € (-2,44 %)     AB INBEV 71.500 € (+1,10 %)     ELIA GROUP 139.400 € (+3,18 %)     CENERGY 20.120 € (-2,14 %)     SOFINA 227.000 € (+0,27 %)     WDP 22.380 € (+1,63 %)     UMICORE 18.750 € (-2,70 %)     DEME GROUP 168.400 € (-1,98 %)     ACKERMANS V.HAAREN 268.000 € (-1,11 %)     RETAIL ESTATES 68.400 € (+0,15 %)     RECTICEL 11.640 € (-1,36 %)     D'IETEREN GROUP 174.300 € (-0,57 %)     AGEAS 71.850 € (+1,13 %)     MONTEA 68.100 € (+1,04 %)     BEKAERT 40.950 € (-0,85 %)     AEDIFICA 70.550 € (+1,00 %)     NYXOAH 1.436 € (-2,45 %)     SOLVAY 26.020 € (-0,61 %)     XIOR 28.000 € (+0,90 %)     SIPEF 91.800 € (+0,77 %)     VAN DE VELDE 30.200 € (+0,67 %)     GBL 78.200 € (+0,51 %)     TUBIZE-FIN 205.000 € (-1,25 %)     TESSENDERLO 21.200 € (+0,47 %)     BPOST 1.586 € (-0,13 %)     KBC ANCORA 84.700 € (-1,05 %)     GIMV 44.400 € (-0,78 %)     PROXIMUS 6.185 € (+0,90 %)     CELYAD ONCOLOGY 0.238 € (-7,75 %)     AGFA-GEVAERT 0.402 € (+0,12 %)     VGP 81.100 € (+0,62 %)     JENSEN-GROUP 85.400 € (-0,70 %)     LOTUS BAKERIES 11 020.000 € (-0,18 %)     ASCENCIO 51.900 € (0,00 %)     TITAN S.A. 49.480 € (-0,72 %)     WERELDHAVE BELGIUM 52.000 € (-2,62 %)     SHURGARD 26.800 € (+0,37 %)     EVS 26.500 € (-0,56 %)     AZELIS GROUP 10.750 € (-2,09 %)     COLRUYT 38.280 € (+0,26 %)     CMB.TECH 13.340 € (-3,33 %)     DECEUNINCK 2.175 € (-2,03 %)     ONWARD MEDICAL 2.510 € (+0,80 %)     HOME INVEST BE. 19.220 € (-0,10 %)     FAGRON 23.950 € (-0,42 %)     IBA 16.860 € (-0,82 %)     EXMAR 11.500 € (+1,77 %)     BREDERODE 103.200 € (-0,58 %)     CFE 12.250 € (+1,66 %)     BIOTALYS 2.970 € (0,00 %)     EKOPAK 3.790 € (+1,88 %)     IMMOBEL 21.500 € (-2,27 %)  
   EXOSENS 55.200 € (-0,81 %)     LOUIS HACHETTE 1.738 € (-1,47 %)     ATON 0.012 € (+7,27 %)     FDJ UNITED 23.500 € (+0,77 %)     CEGEDIM 10.300 € (0,00 %)     CVC CAPITAL 14.960 € (+1,70 %)     ABL Diagnostics 2.340 € (+0,86 %)     MAGNUM 16.474 € (+0,62 %)     ID LOGISTICS GROUP 357.000 € (+0,85 %)     AIR FRANCE -KLM 12.480 € (-3,26 %)     SOITEC 85.160 € (-5,57 %)     SAINT GOBAIN 76.340 € (-0,37 %)     SOCIETE GENERALE 74.260 € (-1,88 %)     AIR LIQUIDE 176.440 € (-0,36 %)     AIRBUS 194.020 € (-0,82 %)     CAPGEMINI 92.560 € (+1,47 %)     ALLFUNDS GROUP 8.735 € (+0,23 %)     LAKEFRONT BIOTHER. 25.680 € (-1,15 %)     2CRSI 23.560 € (-3,20 %)     L'OREAL 382.600 € (+0,33 %)     FRANCAISE ENERGIE 34.800 € (-11,79 %)     S.E.B. 50.400 € (+0,88 %)     SAFRAN 326.600 € (-0,76 %)     EIFFAGE 120.700 € (-1,31 %)     SIGNIFY NV 16.210 € (-1,46 %)     COFACE 16.020 € (-0,19 %)     LVMH 494.950 € (-1,62 %)     VALERIO TX 0.563 € (-5,70 %)     ADVICENNE 1.670 € (+3,09 %)     DSM FIRMENICH AG 86.540 € (0,00 %)     CATANA GROUP 1.894 € (-1,87 %)     BE SEMICONDUCTOR 222.300 € (-5,88 %)     HEIJMANS KON 94.100 € (-2,84 %)     KALRAY 7.410 € (-5,00 %)     Vusion 118.500 € (+3,67 %)     VINCI 118.050 € (-1,79 %)     ASML HOLDING 1 522.200 € (-4,77 %)     TELEPERFORMANCE 55.020 € (+1,25 %)     SHELL PLC 37.780 € (+1,42 %)     PUBLICIS GROUPE SA 90.620 € (-0,83 %)     DASSAULT SYSTEMES 18.115 € (-0,82 %)     RENAULT 26.570 € (-1,19 %)     V LANSCHOT KEMPEN 67.600 € (-1,10 %)     STMICROELECTRONICS 52.230 € (-6,72 %)     SANOFI 77.570 € (+0,82 %)     X-FAB 7.165 € (-5,54 %)     MEDIANTECHNOLOGIES 4.040 € (-5,39 %)     BNP PARIBAS ACT.A 101.580 € (-1,32 %)     SCHNEIDER ELECTRIC 259.150 € (-1,97 %)     TOTALENERGIES 70.060 € (+0,68 %)     PERNOD RICARD 66.680 € (+0,94 %)     NN GROUP 78.200 € (+0,26 %)     EUROFINS SCIENT. 70.300 € (+1,15 %)     TEIXEIRA DUARTE 0.466 € (-1,48 %)     KERING 250.600 € (-1,88 %)     STIF 51.000 € (-0,97 %)     ADYEN 849.600 € (-0,52 %)     FORVIA 9.104 € (-1,92 %)     FLOW TRADERS 26.280 € (-0,76 %)     BOLLORE 4.028 € (-0,20 %)  
News Réglementées
04/05/2023 21:45

Cuverd Brings Prescription Costs Savings Solutions to HUB Employer Clients

Cuverd takes the mystery out of getting the lowest out-of-pocket prescription costs for employees and their families struggling to start and stay on needed therapies.

NAPLES, FL / ACCESSWIRE / May 4, 2023 / TranspareRx Corporation, a leading healthcare technology company that developed the next-generation prescription savings platform Cuverd, announced today its partnership with HUB International Limited (HUB), a leading global insurance brokerage and financial services firm, to bring needed relief to HUB health benefit clients and their employees by addressing prescription costs to help improve affordability, adherence and health outcomes.

Cuverd Rx Savings for HUB International
Cuverd Rx Savings for HUB International
Cuverd Rx savings solution for all Americans and HUB International employees and clients

"We are very excited to bring prescription savings plans to HUB benefits clients and share our passion in providing greater transparency to healthcare savings," stated David Harrell, CEO of TranspareRx. "Together we can really make an impact in helping millions of employees struggling to start and stay on their needed medications by making it easier to access all available savings."

Many studies show that high out-of-pocket costs reduce the likelihood that a patient will initiate treatment. Even amongst patients who fill an initial prescription, the high out-of-pocket costs increase the probability that they will delay, skip or stop treatment.

Through Cuverd's proprietary technology, the partnership aims to take the mystery out of medication savings by automatically navigating all options in real-time to deliver the lowest "out-of-pocket" price per medication.

Powered by a simple, user-friendly interface, the app and website automatically navigate all the complexities for each unique user to deliver the lowest "out-of-pocket" price per medication by factoring a multitude of variables in real-time, including medication coverage across 7,000 employers and health plans; estimated copays; eligibility for additional copay savings and other programs; and comparisons to "cash" prices from leading discount card partners. Cuverd also provides less expensive medication alternatives for patients to discuss with their healthcare provider(s).

"HUB recognizes as prescription costs continue to escalate, many employers are forced to pass more of the costs on to their employees via higher deductibles, additional premiums or increased copays," said Jeff Faber, Chief Strategy Officer at HUB. "We are pleased to offer Cuverd's innovative prescription savings app and website to our clients to help automate prescription coverage look up and available savings, as well as less expensive alternatives. We think this tool will really help our clients' employees start and stay on needed medication therapies to improve outcomes and productivity."

About TranspareRx

TranspareRx Corporation encompasses a team of proven industry leaders who all share a passion to deliver better price transparency and savings right into the hands of millions of Americans needing help in understanding their prescription costs and available savings on their rising out-of-pocket prescription costs and benefits. For more information, contact us at partnerships.cuverd.com

About HUB International

Headquartered in Chicago, Illinois, Hub International Limited is a leading full-service global insurance broker and financial services firm providing risk management, insurance, employee benefits, retirement and wealth management products and services. With more than 16,000 employees in offices located throughout North America, HUB's vast network of specialists brings clarity to a changing world with tailored solutions and unrelenting advocacy, so clients are ready for tomorrow. For more information, visit HUB Media Center.

Contact Information

Neil Bajaj
President
nbajaj@cuverd.com

Related Video

https://www.youtube.com/watch?v=AMD79EsXUhI

SOURCE: TranspareRx Corp

.

View source version on accesswire.com:
https://www.accesswire.com/753048/Cuverd-Brings-Prescription-Costs-Savings-Solutions-to-HUB-Employer-Clients

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière